Pilulka Lékárny a.s.

Prague Stock Exchange PINK.PR

Pilulka Lékárny a.s. EBIT Margin for the year ending December 31, 2023: -7.76%

Pilulka Lékárny a.s. EBIT Margin is -7.76% for the year ending December 31, 2023, a -135.16% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Pilulka Lékárny a.s. EBIT Margin for the year ending December 31, 2022 was -3.30%, a -228.59% change year over year.
  • Pilulka Lékárny a.s. EBIT Margin for the year ending December 31, 2021 was -1.00%, a 20.78% change year over year.
  • Pilulka Lékárny a.s. EBIT Margin for the year ending December 31, 2020 was -1.27%, a 55.85% change year over year.
  • Pilulka Lékárny a.s. EBIT Margin for the year ending December 31, 2019 was -2.87%, a -32.04% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Prague Stock Exchange: PINK.PR

Pilulka Lékárny a.s.

CEO Mr. Petr Kasa
IPO Date Oct. 26, 2020
Location United States
Headquarters Drahobejlova 1073/36
Employees 378
Sector Health Care
Industries
Drugstores & Retail Pharmacies Pharmaceuticals
Description

Pilulka Lékárny a.s. operates a chain of pharmacies in the Czech Republic. It operates 140 pharmacies, as well as an e-shop. The company is headquartered in Prague, the Czech Republic.

StockViz Staff

January 15, 2025

Any question? Send us an email